Workflow from Scientific Research

Open access visualization of Workflow, Illustration, Pathway, Retatrutide, GLP-1R
CC-BY
3
Views
0
Likes

Citation

DOI: 10.1038/s41421-024-00700-0

DOI

Retatrutide (LY3437943) possesses combinatorial agonism at GLP-1R, GIPR and GCGR, distinct from the approved GLP-1R agonists (such as semaglutide and exenatide) and GLP-1R/GIPR dual agonist tirzepatide.

#Workflow#Illustration#Pathway#Retatrutide#GLP-1R#GIPR#GCGR#Semaglutide#Exenatide#Tirzepatide#Agonist

Related Plots

Discover More Scientific Plots

Browse thousands of high-quality scientific visualizations from open-access research

Browse All PlotsView Collections